Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles
- 31 December 1994
- journal article
- Published by Elsevier in Research in Virology
- Vol. 145, 215-220
- https://doi.org/10.1016/s0923-2516(07)80025-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pathogenesis of human immunodeficiency virus infection.Microbiological Reviews, 1993
- Ribozymes as Anti-HIV-1 Therapeutic Agents: Principles, Applications, and ProblemsAIDS Research and Human Retroviruses, 1992
- Drug targeting with polyalkylcyanoacrylate nanoparticles:in vitroactivity of primaquine-loaded nanoparticles against intracellularLeishmania donovaniPathogens and Global Health, 1992
- Phagocytosis of Nanoparticles by Human Immunodeficiency Virus (HlV)-Infected Macrophages: A Possibility for Antiviral Drug TargetingPharmaceutical Research, 1992
- Macrophages and the human immunodeficiency virusImmunology Today, 1990
- Infection of monocytes/macrophages by HIV in vitroResearch in Virology, 1990
- REVERSAL OF HIV-PHENOTYPE TO FULMINANT REPLICATION ON MACROPHAGES IN PERINATAL TRANSMISSIONThe Lancet, 1989
- Role of the Mononuclear Phagocyte System in the Development of Acquired Immunodeficiency Syndrome (AIDS)Journal of Leukocyte Biology, 1988
- Primary cultures of human blood-born macrophages grown on hydrophobic teflon membranesJournal of Immunological Methods, 1983
- Distribution and Elimination of Poly(methyl-2-14C-methacrylate) Nanoparticle Radioactivity after Injection in Rats and MiceJournal of Pharmaceutical Sciences, 1979